Today: Sun 19 May 2013
Register & Login:  Register
   Login

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

boys

The following articles have the tag boys

Boys reaching puberty younger

Boys reaching puberty younger

BOYS are reaching puberty up to two years earlier than previous generations, according to US research. However, paediatricians are unsure of the reason.

Boys reaching puberty earlier, researchers unsure why

BOYS are reaching puberty up to two years earlier than previous generations, according to US research.

Universal HPV vax may stymie growth in head and neck cancers

AUSTRALIA’S world-first decision to extend funding of the quadrivalent HPV vaccine to boys will boost protection for girls and reduce the growing burden of head and neck cancers, experts say.

Gardasil for boys gets PBAC green light

CSL Ltd’s revised bid to have adolescent males vaccinated with Gardasil under the National Immunisation Program (NIP) has been accepted.

PBAC to consider Gardasil vax for boys

A SUBMISSION for adolescent boys to be vaccinated with Gardasil under the National Immunisation Program  (NIP) is set for discussion by the Pharmaceutical Benefits Advisory Committee (PBAC) in March. CSL last year filed for the Gardasil listing on the NIP to be extended to make it a "gender neutral program" ( MO , 9 Nov 2010). The PBAC agenda for March posted last night includes the CSL submission to extend the listing to males aged 12-13 years and a catch-up program over two years for males in Year 9. Gardasil, a quadrivalent HPV vaccine ...

Doubts over cost benefit of HPV vaccine for boys

INCLUDING boys in funded HPV vaccination schemes would not be of economic or public health benefit, new research suggests. Modelling by researchers at the Harvard School of Public Health showed that, while obtaining good vaccine coverage of 12-year-old girls was cost-effective, adding boys would not be worthwhile. The study showed that routine immunisation of girls cost less than $US50,000 ($55,342) per quality-adjusted life year (QALY), accepted as within the threshold for cost-effectiveness. But when boys were included, the cost-effectiveness ratio was $90,870 ($100,634) per QALY, taking into account reduced cancers in both sexes and assuming 90% ...

Good for girls… and boys?

A US decision to give the HPV vaccine to boys could provide impetus to the push to subsidise it here, but as Lynnette Hoffman reports there are some ethical issues to be considered first. THE way it stands today, Gardasil is largely considered a women’s thing. To most people, the vaccine that made a national hero of inventor Professor Ian Frazer is known simply as “the cervical cancer vaccine”. Not – it’s worth noting – the HPV vaccine, even though that’s precisely what Gardasil protects against. Marketing a vaccine for a not-so-sexy sexually transmitted ...